Jun 10, 2020 08:54AM
Jun 10, 2020 08:54AM
May 4, 2020 09:20AM
May 4, 2020 07:01AM
May 4, 2020 07:00AM
Mar 13, 2020 04:45PM
Mar 11, 2020 04:05PM Stemline Therapeutics to Host Conference Call on Fourth Quarter 2019 Financial Results on March 16, 2020
Feb 26, 2020 07:30AM
Jan 13, 2020 04:27PM
Jan 13, 2020 04:15PM
Jan 8, 2020 04:15PM
Dec 10, 2019 08:00AM
Dec 6, 2019 06:30PM
Dec 6, 2019 07:01AM Stemline Therapeutics (STML) ighlights Three ELZONRIS Presentations, Including an Oral Presentation in Myelofibrosis, at ASH
Dec 6, 2019 07:00AM
Nov 29, 2019 01:05PM
Nov 7, 2019 04:57PM
Nov 6, 2019 09:15AM
Nov 5, 2019 04:22PM
Oct 8, 2019 07:30AM
Oct 1, 2019 07:30AM Stemline Therapeutics Recaps Felezonexor (SL-801) Clinical Data Presentation From ESMO 2019 Congress
Sep 27, 2019 07:32AM
Sep 27, 2019 07:30AM
Sep 26, 2019 04:01PM
Sep 18, 2019 09:32AM
Sep 5, 2019 07:30AM
Aug 9, 2019 04:00PM
Aug 9, 2019 05:47AM Stemline Therapeutics (STML) Prices 5M Share Common Offering at $15.25/Sh
Aug 8, 2019 10:23PM
Aug 7, 2019 04:25PM
Aug 7, 2019 04:25PM
Aug 6, 2019 07:44AM
Aug 6, 2019 07:30AM
Aug 2, 2019 07:00AM
Jul 29, 2019 07:00AM Stemline Therapeutics to Host Conference Call on Second Quarter 2019 Financial Results on August 2, 2019
Jul 8, 2019 05:50PM
Jun 17, 2019 07:30AM
Jun 13, 2019 07:34AM
Jun 13, 2019 07:30AM
Jun 3, 2019 07:32AM
Jun 3, 2019 07:30AM
May 20, 2019 07:00AM Stemline Therapeutics Announces ELZONRIS Clinical Data Selected for Presentation at Upcoming EHA Annual Congress
May 16, 2019 07:00AM
May 10, 2019 06:30AM
May 8, 2019 07:00AM
Apr 25, 2019 07:00AM
Mar 18, 2019 07:00AM
Mar 15, 2019 04:01PM
Mar 11, 2019 03:00AM Stemline In-Licenses Worldwide Rights to Novel Selective RET Inhibitor (SL-1001); Expands Oncology Pipeline
Mar 6, 2019 07:30AM

322,904 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All